Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy

Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy

<b>Objective</b>: Inflammatory biomarkers have been shown to possess both prognostic and predictive significance in various cancers. Among the emerging biomarkers, the pan-immune-inflammation value (PIV) has recently been introduced as a novel indicator representing both the immune respo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Timur Koca, Nurcihan Gocen Vardar, Rahmi Atıl Aksoy, Aylin Fidan Korcum
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Current Oncology
Subjects:	cervical cancer inflammation biomarkers chemotherapy radiotherapy survival
Online Access:	https://www.mdpi.com/1718-7729/32/1/39
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Addition of PARP1-inhibition enhances chemoradiotherapy and thermoradiotherapy when treating cervical cancer in an in vivo mouse model
by: Marloes IJff, et al.
Published: (2025-12-01)

Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer
by: Zhe Chen, et al.
Published: (2025-01-01)

Elevated POSTN expression predicts poor prognosis and is associated with radioresistance in cervical cancer patients treated with radical radiotherapy
by: Cui-qin Huang, et al.
Published: (2025-02-01)

Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
by: Sha Ji, et al.
Published: (2025-01-01)

Construction and evaluation of a prognostic model for cervical cancer based on dynamic hematological and clinical features
by: Huangrong Ma, et al.
Published: (2025-02-01)

Prognostic significance of tumor angiogenesis markers in advanced cervical cancer undergoing chemotherapy
by: I Nyoman Bayu Mahendra, et al.
Published: (2024-12-01)

The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers
by: Terkimbi Dominic Swase, et al.
Published: (2025-02-01)

Impact of thoracic radiotherapy on first‐line treatment outcomes in ES‐SCLC patients
by: Xiaoli Mu, et al.
Published: (2024-09-01)

Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01)

Exploring and detecting predictors associated with survival and mortality of cervical cancer patients: a 10-year retrospective study
by: Shaba Muneeha, et al.
Published: (2025-02-01)

MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer
by: Kari S. Wagner-Larsen, et al.
Published: (2025-01-01)

CircRNAs as Possible Potential Biomarkers for Breast Cancer Prognosis and Chemotherapy Response: A Comprehensive Study
by: Saba Mirzaei, et al.
Published: (2024-10-01)

Predicting High-Grade Acute Urinary Toxicity and Lower Gastrointestinal Toxicity After Postoperative Volumetric Modulated Arc Therapy for Cervical and Endometrial Cancer Using a Normal Tissue Complication Probability Model
by: Tianyu Yang, et al.
Published: (2025-01-01)

Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
by: Meng Yan, et al.
Published: (2025-01-01)

Breast Cancer: Epidemiology, Risk Factors and Survival Analysis in the Pakistani Population
by: Shumaila Zaib, et al.
Published: (2024-01-01)

ConvXGB: A novel deep learning model to predict recurrence risk of early-stage cervical cancer following surgery using multiparametric MRI images
by: Ji Wu, et al.
Published: (2025-02-01)

Association between serum levels of 12 different cytokines and short-term efficacy of chemoradiotherapy in esophageal squamous cell carcinoma
by: Yaping Zhang, et al.
Published: (2025-01-01)

Thyroid Dysfunction following Radiotherapy and Combined Therapy in Non-Thyroid Head and Neck Cancers
by: Rais Ahmad Bhat, et al.
Published: (2023-12-01)

Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial
by: Łukasz Kuncman, et al.
Published: (2025-01-01)

Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer
by: Xun Kan, et al.
Published: (2025-02-01)

Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy
by: Eminagić Dzenana, et al.
Published: (2019-12-01)

The Role of IL-6 and TNF-Alpha Biomarkers in Predicting Disability Outcomes in Acute Ischemic Stroke Patients
by: Ciprian-Ionuț Băcilă, et al.
Published: (2025-01-01)

Biomarker‐induced gold aggregates enable activatable near‐infrared‐II photoacoustic image‐guided radiosensitization
by: Qinrui Fu, et al.
Published: (2025-01-01)

Addressing Methodological and Generalizability Challenges in Cervical Rotation-Traction Manipulation (CRTM) for Cervical Radiculopathy [Letter]
by: Wang R, et al.
Published: (2025-01-01)

Serum cardiac and inflammatory biomarker levels following chemotherapy among female patients with breast cancer attending at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
by: Muluabay Getie, et al.
Published: (2025-01-01)

Endoscopy-assisted anterior cervical discectomy and fusion with internal fixation vs conventional surgery in the treatment of cervical disc herniation
by: Haicun Zhang, et al.
Published: (2024-07-01)

Collagenase Chemonucleolysis for Treating Cervical Disc Herniation: An Exploratory, Single-Arm, Open-Label, Multicenter Clinical Trial
by: Zhijian Wang, et al.
Published: (2024-11-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01)

The importance of inflammatory biomarkers in detecting and managing latent tuberculosis infection
by: Harinisri Gunasekaran, et al.
Published: (2025-02-01)

Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer
by: Baoli Li, et al.
Published: (2025-01-01)

Systematic review and meta-analysis of T1 glottic cancer outcomes comparing CO2 transoral laser microsurgery and radiotherapy
by: Michael F. Vaculik, et al.
Published: (2019-09-01)

Resistance to Radiotherapy in Cancer
by: Almaz A. Akhunzianov, et al.
Published: (2025-01-01)

Diagnostic Dilemmas in Carpal Tunnel Syndrome and Cervical Spine Disorders: A Comprehensive Review
by: Yuki Hara, et al.
Published: (2025-01-01)

Stand-Alone Cervical Cage for Cervical Radiculopathy: A Retrospective Study
by: I Ketut Martiana, et al.
Published: (2020-04-01)

Clinical efficacy and learning curve of percutaneous endoscopic cervical discectomy for symptomatic cervical spondylotic radiculopathy
by: Xiao Sun, et al.
Published: (2025-02-01)

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma
by: Francesca Huwyler, et al.
Published: (2024-12-01)

Relationship Between Short‐Term Outcomes and PD‐L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti‐PD‐1 Antibody Monotherapy
by: Akihiro Ohara, et al.
Published: (2025-01-01)

Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients
by: Gati K. Panigrahi, et al.
Published: (2019-03-01)

Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
by: L. S. Franco, et al.
Published: (2025-01-01)

Pilot application of an inflammation and physiological dysregulation index based on noninvasive salivary biomarkers
by: Andrey I. Egorov, et al.
Published: (2025-02-01)